F19.2 Other psychoactive substance dependence

Name of the Condition

• Other Psychoactive Substance Dependence
• ICD-10 Code: F19.2

Summary

Other psychoactive substance dependence refers to a pattern of substance use that leads to clinically significant impairment or distress, characterized by a strong desire to use the substance, difficulty controlling use, and continued use despite negative consequences. This condition involves substances not classified under more specific categories (e.g., alcohol, opioids, cannabis) and may include dependence on agents like caffeine, nicotine, or other non-specified psychoactive substances.

Causes

The causes of this condition can include chronic use of psychoactive substances that alter brain function, psychological factors such as stress or trauma, and social influences like peer pressure. The addictive potential of these substances, combined with repeated use, can lead to dependence over time.

Risk Factors

• Genetic predisposition to addiction
• Co-occurring mental health disorders (e.g., anxiety, depression)
• Early exposure to psychoactive substances
• Environmental factors (e.g., access to substances, social norms)

Symptoms

• Intense cravings or urges to use the substance
• Inability to reduce or control use despite efforts
• Withdrawal symptoms when not using (e.g., irritability, fatigue)
• Neglect of personal, occupational, or social responsibilities
• Continued use despite physical or psychological harm

Diagnosis

Diagnosis is based on a clinical evaluation, including a detailed history of substance use, patterns of use, and impact on daily functioning. Healthcare providers may use standardized criteria (e.g., DSM-5) to assess dependence and rule out other conditions. No specific lab tests are required, but physical exams or screenings may be used to identify related health issues.

Treatment Options

Treatment typically involves a combination of approaches:

• Detoxification to manage withdrawal symptoms under medical supervision
• Behavioral therapies (e.g., cognitive-behavioral therapy) to address underlying triggers
• Support groups or counseling to provide ongoing encouragement
• Medications to reduce cravings or treat co-occurring conditions (if applicable)

Prognosis and Follow-Up

Prognosis varies depending on the severity of dependence, co-occurring conditions, and adherence to treatment. Long-term follow-up is often necessary to monitor for relapse and adjust care plans. Early intervention and consistent support improve outcomes.

Complications

• Worsening of mental health conditions (e.g., depression, anxiety)
• Physical health issues (e.g., organ damage, infections)
• Social or occupational impairment (e.g., job loss, relationship problems)
• Increased risk of overdose or substance-related accidents

Lifestyle & Prevention

• Avoiding exposure to non-classified psychoactive substances
• Developing healthy coping mechanisms for stress
• Building a strong support network (e.g., family, friends, support groups)
• Seeking education on the risks of substance use

When to Seek Professional Help

Seek help if you or someone you know experiences:

• Inability to stop using a substance despite negative consequences
• Withdrawal symptoms when not using
• Neglect of responsibilities or relationships due to substance use
• Persistent cravings or loss of control over use

Tips for Medical Coders

When coding F19.2, ensure documentation supports a diagnosis of dependence (e.g., cravings, withdrawal, impaired control) related to non-classified psychoactive substances. Verify that the substance is not covered by a more specific code (e.g., alcohol, opioids) and that the clinical criteria for dependence are met. Document the substance type and any associated symptoms or complications to support accurate coding.